[Effects of combination of anti-epileptic drugs].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D004074:Digitoxin / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D013843:Thiazines; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D011324:Primidone; D002220:Carbamazepine; D010672:Phenytoin; D014044:Tolbutamide; D008094:Lithium; D004074:Digitoxin; D010634:Phenobarbital
Wirkungen aus der Kombination von Antiepeleptika